Qun Zhao

ORCID: 0000-0001-9712-3135
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Cervical Cancer and HPV Research
  • Colorectal and Anal Carcinomas
  • S100 Proteins and Annexins
  • Ovarian cancer diagnosis and treatment
  • Cancer Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Urological Disorders and Treatments
  • Gastric Cancer Management and Outcomes
  • Genital Health and Disease
  • Connective Tissue Growth Factor Research
  • Lung Cancer Treatments and Mutations
  • Cancer-related gene regulation

Capital Medical University
2008-2019

Beijing Obstetrics and Gynecology Hospital
2008-2019

Gynecologic Oncology Group
2014

The purpose of this study is to investigate short-term efficacy as defined by the Response Evaluation Criteria in Solid Tumors (RECIST) and pathological response neoadjuvant chemotherapy (NACT) comprised paclitaxel cisplatin (TP) followed radical surgery patients with locally advanced cervical cancer (LACC).This a prospective involving 61 women histologically confirmed LACC referred for NACT following at Beijing Obstetrics Gynecology Hospital between April 2013 January 2015.The was evaluated...

10.1097/md.0000000000010913 article EN cc-by-nc Medicine 2018-05-31

Objective The aim of the study is to evaluate clinical value cold knife conization (CKC) as a conservative management in patients with microinvasive cervical squamous cell cancer (SCC). Methods This retrospective enrolled 108 women diagnosis SCC (stage IA1) by pathology between 2009 2012 at Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Eighty-three underwent further hysterectomy. Results Of 83 (76.9%) who hysterectomy, 48 (57.8%) extrafascial 30 (36.1%) extensive 5...

10.1097/igc.0000000000000199 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2014-07-02

This was a two-phase, large sample-group study assessing the effectiveness of combined transvaginal sonography (TVS) and endometrial cytology in cancer screening. In phase one, 3308 women without known were enrolled TVS performed on those with symptoms or risk factors. Endometrial carried out post-menopausal thickness ≥ 5 mm pre-menopausal 10 mm. Dilation curettage (D & C) if cytological findings inconclusive, indicated pre-cancer. The mass screening safety interval is at least 2 years...

10.1177/147323001003800307 article EN Journal of International Medical Research 2010-06-01

To investigate the relationship between cervical intraepithelial neoplasia (CIN) and high-risk human papilloma virus (HR-HPV) during pregnancy postpartum in China.In this prospective case-control study, 168 pregnant women with CIN cervicitis were diagnosed by colposcopic biopsy. All cases underwent hybrid capture assay version II (HCII) to detect HR-HPV DNA load amounts tests completed 3-6 months after childbirth.During pregnancy: as grade increased, infection rates increased (P = 0.002),...

10.1111/jog.12192 article EN Journal of Obstetrics and Gynaecology Research 2013-10-11

e17002 Background:The purpose of this study is to observe the short-term efficacy and pathological outcomes paclitaxel combined with platinum (TP) as neoadjuvant chemotherapy (NACT) regimen in patients locally advanced cervical cancer (LACC). Methods: This a prospective involving 61 women histologically confirmed LACC referred for NACT at Beijing Obstetrics Gynecology Hospital between April 2013 January 2015. Results: The was evaluated by Response Evaluation Criteria Solid Tumors (RECIST)....

10.1200/jco.2017.35.15_suppl.e17002 article EN Journal of Clinical Oncology 2017-05-20

Objective To investigate clinical applications of hybrid capture (HC)2 and Cervista methods to detect high-risk human papillomavirus (HR-HPV) in cervical lesion screening. Methods From January 1 December 31, 2015, a total 155 women who underwent ThinPrep liquid-based cytology test (TCT) screening two other HR-HPV detection (HC2 methods) simultaneously the Department Gynecological Oncology Clinic at Beijing Obstetrics Gynecology Hospital, Capital Medical University, were chosen as...

10.3877/cma.j.issn.1673-5250.2017.04.014 article EN Chung-Hua Fu Ch'an K'o Tsa Chih 2017-08-01

<h3>Objectives</h3> To explore the differentially expressed proteins in normal cervix, cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (CSCC) tissues by differential proteomics technique. <h3>Methods</h3> Cervical (including CIN CSCC) were collected Department of Gynecologic Oncology Beijing Obstetrics Gynecology Hospital. 2-D DIGE) DeCyder software used to detect proteins. MALDI-TOF/TOF MS was identify WB IHC performed validate expressions selected among CSCC....

10.1136/ijgc-2019-igcs.123 article EN 2019-09-01
Coming Soon ...